The dearth of antibiotic development (AAC ed.)
Editors in Conversation
English - September 02, 2020 20:57 - 43 minutes - 30.1 MB - ★★★★ - 10 ratingsLife Sciences Science Health & Fitness Medicine asm for fox interviews jeff magazine microbe microbiology news science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Detection of carbapenemases (JCM ed.)
Next Episode: Parasites (JCM ed.)
Why are we running out of antibiotics? A look at the pharmaceutical development of one of the most life-saving class of drugs.
Topics discussed:
The reasons behind the stagnant and declining antibiotic development pipeline New initiatives focused on stimulating the antibiotic market Strategies to spur the antibiotic developmentGuests:
Helen Boucher, MD. Professor of Medicine and Chief, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Editor of AAC Karen Bush, PhD. Professor of Practice & Interim Director, Biotechnology ProgramIndiana University. Former Editor AAC.
Visit aac.asm.org to read current and archived issues of the Antimicrobial Agents and Chemotherapy journal.